His Royal Highness was appointed as the Patron of a newly established appeal aimed at establishing The Fleming Centre by 2023.
Situated at St.
Mary’s Hospital in Paddington, London, the establishment of the Centre is spearheaded by Imperial College London and Imperial College Healthcare NHS Trust.
It is anticipated to spearhead a global drive to tackle AMR.
AMR emerges when the microbes responsible for infections develop resistance to treatments like antibiotics, making infections challenging or even impossible to cure.
This escalation heightens the threat of disease transmission, severe illness, disability, and mortality.
Antimicrobial resistance poses a significant peril to our health, environment, livelihoods, and future.
Unless decisive action is taken collectively and promptly, the repercussions of drug resistance will reverberate across generations, imperiling the health of our offspring and grandchildren.
The occasion, hosted at the Royal Society in London, showcased the newest scientific and economic research on antimicrobial resistance, celebrated campaigns aimed at raising awareness about the issue, and was a part of the progression towards an upcoming High-Level Meeting on this issue at the United Nations General Assembly in September.
At the event, survivors of AMR shared their personal encounters, and Professor the Lord Darzi of Denham, Chair of the Fleming Initiative, briefed attendees on the progress of the Initiative thus far, including updates on The Fleming Centre.